| __timestamp | Halozyme Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 79696000 | 21263000 |
| Thursday, January 1, 2015 | 93236000 | 18890000 |
| Friday, January 1, 2016 | 150842000 | 15295000 |
| Sunday, January 1, 2017 | 150643000 | 12944000 |
| Monday, January 1, 2018 | 150252000 | 13599000 |
| Tuesday, January 1, 2019 | 140804000 | 30391000 |
| Wednesday, January 1, 2020 | 34236000 | 13020000 |
| Friday, January 1, 2021 | 35672000 | 16287000 |
| Saturday, January 1, 2022 | 66607000 | 19943000 |
| Sunday, January 1, 2023 | 76363000 | 21042000 |
| Monday, January 1, 2024 | 79048000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Halozyme Therapeutics, Inc. and Vericel Corporation have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Halozyme consistently outspent Vericel, with its R&D expenses peaking in 2016 at nearly 150% more than Vericel's highest expenditure in 2019. Despite a dip in 2020, Halozyme's R&D spending rebounded, maintaining a steady lead over Vericel. This trend underscores Halozyme's strategic focus on innovation, potentially positioning it for greater breakthroughs in the competitive biotech landscape. Meanwhile, Vericel's more conservative R&D spending reflects a different strategic approach, possibly prioritizing operational efficiency or other business areas. As the biotech industry continues to grow, these spending patterns offer valuable insights into each company's future trajectory.
R&D Spending Showdown: AbbVie Inc. vs Vericel Corporation
Research and Development Expenses Breakdown: GSK plc vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Biogen Inc. or Vericel Corporation: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
R&D Spending Showdown: Bio-Techne Corporation vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and MiMedx Group, Inc.